Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jan 4, 2010

Premium

Pacific Biometrics last month announced the appointment of Michael Murphy as its chief operating officer.

Murphy had been the Seattle-based firm's senior vice president of operations from May 2005 to October 2009, where he managed all aspects of the company's operations, including laboratory operations, client and information services, business development, and quality assurance.

Prior to that, he was technical director at Laboratory Corporation of America. He also served in leadership positions at a number of healthcare and research centers, including Eastern Maine Medical Center and CompuLab.

Last month, the company said its shareholders had approved the changing of its name to Pacific Biomarkers. The company provides specialized central laboratory and contract research services to drug firms and diagnostic manufacturers and works with protein, peptide, metabolite, and bioassay biomarkers.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.